Discover how CRID3, an experimental compound targeting inflammasomes, shows promise in treating spinal cord injury by modifying the immune response and promoting recovery.
Understanding how programmed cell death amplifies spinal cord injury damage and the promising therapeutic approaches to block this destructive process.